Rapport Therapeutics, Inc. - Common Stock, $0.001 par value (RAPP)

Historical Holders from Q2 2024 to Q3 2025

Symbol
RAPP on Nasdaq
CUSIP
75383L102
Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
36.4M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
38.5M
Holdings value
$438M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
81
Number of buys
41
Number of sells
-28
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Rapport Therapeutics, Inc. - Common Stock, $0.001 par value (RAPP)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Third Rock Ventures V, L.P. 19.5% $66.1M 7.14M Third Rock Ventures V, L.P. Dec 31, 2024
Sofinnova Venture Partners XI, L.P. 4.2% $29.2M 1.95M Dr. James I. Healy ("Healy") Sep 11, 2025
JOHNSON & JOHNSON 4.9% $53M 1.78M JOHNSON & JOHNSON Sep 30, 2025

Institutional Holders of Rapport Therapeutics, Inc. - Common Stock, $0.001 par value (RAPP)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 33.1K $983K +$585K $29.70 10
2025 Q2 38.5M $438M +$4.9M $11.37 81
2025 Q1 38.1M $382M +$11.2M $10.03 77
2024 Q4 36.6M $649M +$1.21M $17.74 69
2024 Q3 28.4M $580M +$35.9M $20.48 54
2024 Q2 25.6M $593M +$593M $23.26 35